Advertisement

The Editor's Roundtable: Role of Percutaneous Coronary Intervention and Drug-Eluting Stents in Patients With Stable Coronary Heart Disease

  • Vincent E. Friedewald
    Correspondence
    Corresponding author: Tel: 830-693-2220; fax: 830-798-0194
    Affiliations
    Moderator and Associate Editor, The American Journal of Cardiology, and Research Professor, University of Notre Dame, Notre Dame, Indiana
    Search for articles by this author
  • William E. Boden
    Affiliations
    Clinical Chief, Division of Cardiovascular Medicine, and Professor of Medicine and Preventive Medicine, University at Buffalo, State University of New York School of Medicine and Biomedical Sciences and Public Health, Buffalo, New York
    Search for articles by this author
  • Gregg W. Stone
    Affiliations
    Professor of Medicine, Columbia University, and Director of Cardiovascular Research and Education, Center for Interventional Vascular Therapy, Columbia University Medical Center, New York, New York
    Search for articles by this author
  • Clyde W. Yancy
    Affiliations
    Medical Director, Baylor Heart and Vascular Institute, Chief, Cardiothoracic Transplantation, Baylor University Medical Center, Dallas, Texas
    Search for articles by this author
  • William C. Roberts
    Affiliations
    Editor-in-Chief, The American Journal of Cardiology and Baylor University Medical Center Proceedings, Executive Director, Baylor Heart and Vascular Institute, Baylor University Medical Center, and Dean, A. Webb Roberts Center for Continuing Medical Education of Baylor Health Care System, Dallas, Texas
    Search for articles by this author
      This CME activity is supported by an educational grant from Abbott Vascular, Abbott Park, Illinois.
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to American Journal of Cardiology
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • American Heart Association
        Heart Disease and Stroke Statistics—2009 Update.
        American Heart Association, Dallas, Texas2009
        • Gibbons R.J.
        • Chatterjee K.
        • Daley J.
        • Douglas J.S.
        • Fihn S.D.
        • Gardin J.M.
        • Grunwald M.A.
        • Levy D.
        • Lytle B.W.
        • O'Rourke R.A.
        • Schafer W.P.
        • Williams S.V.
        ACC/AHA/ACP-ASIM guidelines for the management of patients with chronic stable angina: executive summary and recommendations.
        Circulation. 1999; 99: 2829-2848
        • Cohn P.F.
        • Fox K.M.
        Silent myocardial ischemia.
        Circulation. 2003; 108: 1263
        • Davies R.F.
        • Goldberg A.D.
        • Forman S.
        • Pepine C.J.
        • Knatterud G.L.
        • Geller N.
        • Sopko G.
        • Pratt P.
        • Deanfield J.
        • Conti C.R.
        • ACIP Investigators
        Asymptomatic Cardiac Ischemia Pilot (ACIP) study two-year follow-up.
        Circulation. 1997; 95: 2037-2043
        • Madsen J.K.
        • Grande P.
        • Saunamäki K.
        • Thayssen P.
        • Kassis E.
        • Eriksen U.
        • Rasmussen K.
        • Haunsø S.
        • Nielsen T.T.
        • Haghfelt T.
        • Fritz-Hansen P.
        • Hjelms E.
        • Paulsen P.K.
        • Alstrup P.
        • Arendrup H.
        • Niebuhr-Jørgensen U.
        • Andersen L.I.
        • DANAMI Study Group
        Danish Multicenter Randomized Study of Invasive Versus Conservative Treatment in Patients With Inducible Ischemia After Thrombolysis in Acute Myocardial Infarction (DANAMI).
        Circulation. 1997; 96: 748-755
        • Boden W.E.
        • O'Rourke R.A.
        • Teo K.K.
        • Hartigan P.M.
        • Maron D.J.
        • Kostuk W.J.
        • Knudtson M.
        • Dada M.
        • Casperson P.
        • Harris C.L.
        • Chaitman B.R.
        • Shaw L.
        • Gosselin G.
        • Nawaz S.
        • Title L.M.
        • Gau G.
        • Blaustein A.S.
        • Booth D.C.
        • Bates E.R.
        • Spertus J.A.
        • Berman D.S.
        • Mancini G.B.
        • Weintraub W.S.
        • COURAGE Trial Research Group
        Optimal medical therapy with or without PCI for stable coronary disease.
        N Engl J Med. 2007; 356: 1503-1516
        • Erne P.
        • Schoenenberger A.W.
        • Burckhardt D.
        • Zuber M.
        • Kiowski W.
        • Buser P.T.
        • Dubach P.
        • Resink T.J.
        • Pfisterer M.
        Effects of percutaneous coronary interventions in silent ischemia after myocardial infarction.
        JAMA. 2007; 297: 1985-1991
        • Zellweger M.J.
        • Kaiser C.
        • Brunner-La Rocca H.P.
        • Buser P.T.
        • Osswald S.
        • Weiss P.
        • Mueller-Brand J.
        • Pfisterer M.E.
        • BASKET Investigators
        Value and limitations of target-vessel ischemia in predicting late clinical events after drug-eluting stent implantation.
        J Nucl Med. 2008; 49: 550-556
        • Schomig A.
        • Mehilli J.
        • de Waha A.
        • Seyfarth M.
        • Pache J.
        • Kastrati A.
        A meta-analysis of 17 randomized trials of a percutaneous coronary intervention-based strategy in patients with stable coronary artery disease.
        J Am Coll Cardiol. 2008; 52: 894-904
        • Jeremias A.
        • Kaul S.
        • Rosengart T.K.
        • Gruberg L.
        • Brow D.L.
        The impact of revascularization on mortality in patients with nonacute coronary artery disease.
        Am J Med. 2009; 122: 152-161
        • Bhatt D.L.
        • Roe M.T.
        • Peterson E.D.
        • Li Y.
        • Chen A.Y.
        • Harrington R.A.
        • Greenbaum A.B.
        • Berger P.B.
        • Cannon C.P.
        • Cohen O.J.
        • CRUSADE Investigators
        Utilization of early invasive management strategies for high-risk patients with non-ST-segment elevation acute coronary syndromes: results from the CRUSADE Quality Improvement Initiative.
        JAMA. 2004; 292: 2096-2104
        • Shaw L.J.
        • Berman O.S.
        • Maron O.J.
        • Mancini G.B.J.
        • Hayes S.W.
        • Hartigan P.M.
        • Weintraub W.S.
        • O'Rourke R.A.
        • Dada M.
        • Spertus J.A.
        • Chaitman B.R.
        • Friedman J.
        • Slomka P.
        • Heller G.V.
        • Germano G.
        • Gosselin G.
        • Berger P.
        • Kostuk W.J.
        • Schwartz R.G.
        • Knudtson M.
        • Veledar E.
        • Bates E.R.
        • McCallister B.
        • Teo K.T.
        • Boden W.E.
        • COURAGE Investigators
        Optimal medical therapy with or without percutaneous coronary intervention to reduce ischemic burden: results from the Clinical Outcomes Utilizing Revascularization and Aggressive Drug Evaluation (COURAGE) Trial Nuclear Substudy.
        Circulation. 2008; 117: 1283-1291
        • Lin G.A.
        • Dudley R.A.
        • Lucas F.L.
        • Malenka O.J.
        • Vittinghoff E.
        • Redberg R.F.
        Frequency of stress testing to document ischemia prior to elective percutaneous coronary intervention.
        JAMA. 2008; 300: 1765-1773
        • Serruys P.W.
        • Morice M.-C.
        • Kappetein A.P.
        • Colombo A.
        • Holmes D.R.
        • Mack M.J.
        • Stahle E.
        • Feldman T.E.
        • van den Brand M.
        • Bass E.J.
        • Van Dyck N.
        • Leadley K.
        • Dawkins K.D.
        • Mohr F.W.
        • SYNTAX Investigators
        Percutaneous coronary intervention versus coronary-artery bypass grafting for severe coronary artery disease.
        N Engl J Med. 2009; 360: 961-972
        • Bhatt D.L.
        • Flather M.D.
        • Hacke W.
        • Berger P.B.
        • Black H.R.
        • Boden W.E.
        • Cacoub P.
        • Cohen E.A.
        • Creager M.A.
        • Easton J.D.
        • CHARISMA Investigators
        Patients with prior myocardial infarction, stroke, or symptomatic peripheral arterial disease in the CHARISMA trial.
        J Am Coll Cardiol. 2007; 49: 1982-1988
        • Farkouh M.E.
        • Dangas G.
        • Leon M.B.
        • Smith C.
        • Nesto R.
        • Buse J.B.
        • Cohen O.J.
        • Mahoney E.
        • Sleeper L.
        • King III, S.
        • Domanski M.
        • McKinlay S.
        • Fuster V.
        Design of the Future Revascularization Evaluation in Patients With Diabetes Mellitus: Optimal Management of Multivessel Disease (FREEDOM) trial.
        Am Heart J. 2008; 155: 215-223
        • Morrow D.A.
        • Scirica B.M.
        • Karwatowska-Prokopczuk E.
        • Murphy S.A.
        • Budaj A.
        • Varshavsky S.
        • Wolff A.A.
        • Skene A.
        • McCabe C.H.
        • Braunwald E.
        • MERLIN-TIMI 36 Trial Investigators
        Effects of ranolazine on recurrent cardiovascular events in patients with non-ST-elevation acute coronary syndromes: the MERLIN-TIMI 36 randomized trial.
        JAMA. 2007; 297: 1775-1783
        • Ridker P.M.
        • Danielson E.
        • Fonseca F.A.H.
        • Genest J.
        • Gotto Jr, A.M.
        • Kastelein J.P.
        • Koenig W.
        • Libby P.
        • Lorenzatti A.J.
        • MacFadyen J.G.
        • Nordestgaard B.G.
        • Shepherd J.
        • Willerson J.T.
        • Glynn R.J.
        Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein.
        N Engl J Med. 2008; 359: 2195-2207
        • Wolfram R.W.
        • Brewer H.B.
        • Xue Z.
        • Sader L.F.
        • Pichard A.D.
        • Kent K.M.
        • Waksman R.
        Impact of low high-density lipoproteins on in-hospital events and one-year clinical outcomes in patients with non-ST-elevation myocardial infarction acute coronary syndrome treated with drug-eluting stent implantation.
        Am J Cardiol. 2006; 98: 711-717
        • Cannon C.P.
        • Braunwald E.
        • McCabe C.H.
        • Rader O.J.
        • Rouleau J.L.
        • Belder R.
        • Joyal S.V.
        • Hill K.A.
        • Pfeffer M.A.
        • Skene A.M.
        • Pravastatin or Atorvastatin Evaluation and Infection Therapy–Thrombolysis In Myocardial Infarction 22 Investigators
        Intensive versus moderate lipid lowering with statins after acute coronary syndromes.
        N Engl J Med. 2004; 350: 1495-1504
        • Stone G.W.
        • White H.D.
        • Ohman E.M.
        • Bertrand M.E.
        • Lincoff A.M.
        • McLaurin B.T.
        • Cox D.A.
        • Pocock S.J.
        • Ware J.H.
        • Feit F.
        • Acute Catheterization and Urgent Intervention Triage Strategy (ACUITY) Trial Investigators
        Bivalirudin in patients with acute coronary syndromes undergoing percutaneous coronary intervention: a subgroup analysis from the Acute Catheterization and Urgent Intervention Triage Strategy (ACUITY) trial.
        Lancet. 2007; 369: 907-919
        • Stone G.W.
        • Midei M.
        • Newman W.
        • Sanz M.
        • Hermiller J.B.
        • Williams J.
        • Farhat N.
        • Mahaffey K.W.
        • Cutlip D.E.
        • Fitzgerald P.L.
        • Sood P.
        • Su X.
        • Lansky A.L.
        • SPIRIT III Investigators
        Comparison of an everolimus-eluting stent and a paclitaxel-eluting stent in patients with coronary artery disease: a randomized trial.
        JAMA. 2008; 299: 1903-1913
        • Patei M.R.
        • Dehmer G.C.
        • Hirshfeld L.W.
        • Smith P.K.
        • Spertus L.A.
        ACCF/SCA/STS/AATS/AHA/ASNC 2009 appropriateness criteria for coronary revascularization.
        Circulation. 2009; 119: 1330-1352